Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14731
Articles
Company
Deals
Huadong Medicine Expands Global Partnership with Scohia Pharma for SCO-094
January 18, 2025
Company
Drug
Zai Lab’s SUL-DUR NDA Accepted for Review by NMPA
January 18, 2025
Company
Deals
Changchun BCHT Biotechnology and IMB CAMS Enter Five-Year Research Pact
January 18, 2025
Company
Deals
Lepu and Keymed License CLDN18.2 ADC CMG901 to AstraZeneca
February 11, 2025
Company
Legend Biotech No Longer Faces Delisting from Nasdaq
January 18, 2025
Company
Drug
Abbisko’s ABSK121 Greenlit for Phase I Clinical Study by NMPA
January 18, 2025
Company
Medical Device
MicroPort CardioFlow’s TAVI Product Approved in Thailand
January 18, 2025
Company
Deals
TransThera Biosciences Completes Series D+ Financing Round
January 18, 2025
Company
Drug
Shanghai Pharmaceuticals’ WST01 Receives FDA Clinical Clearance
January 18, 2025
Company
Deals
Huahai Pharma Raises Funds for Digital Manufacturing and API Platform
January 18, 2025
Company
Deals
Zai Lab Partners with Sir Run Run Shaw Hospital for Medical Innovation Center
January 18, 2025
Company
Drug
Huadong Medicine’s Patent Challenge Against Novo Nordisk’s Ozempic Heads to Hearing
January 18, 2025
1
2
…
1,050
1,051
1,052
1,053
1,054
…
1,227
1,228
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
